Selected research
Industry Research
Human Growth Hormone Drugs Industry Research Report 2026
Market perspective
The global Human Growth Hormone Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Growth Hormone Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Growth Hormone Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Growth Hormone Drugs include Novo Nordisk A/S (Denmark), Merck KgaA (Germany), Eli Lilly and Company (US), Pfizer, Inc. (US), Ferring Holding SA (Switzerland), Sandoz International GmbH (Germany), GeneScience Pharmaceuticals Co., Ltd. (China) and Genentech, Inc. (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Growth Hormone Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Growth Hormone Drugs Market by Company
Novo Nordisk A/S (Denmark)
Merck KgaA (Germany)
Eli Lilly and Company (US)
Pfizer, Inc. (US)
Ferring Holding SA (Switzerland)
Sandoz International GmbH (Germany)
GeneScience Pharmaceuticals Co., Ltd. (China)
Genentech, Inc. (US)
Human Growth Hormone Drugs Segment by Type
Saizen
Genotropin
Humatrope
Norditropin
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Human Growth Hormone Drugs Segment by Application
Small for Gestational Age
Turner Syndrome
Prader-Willi Syndrome
Chronic Renal Insufficiency
Short Bowel Syndrome
Short Stature Homeobox Gene
Human Growth Hormone Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Growth Hormone Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Growth Hormone Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Growth Hormone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Saizen
- Genotropin
- Humatrope
- Norditropin
- Omnitrope - the Somatropin Biosimilar
- Somatropin Biopartners
Applications
- Small for Gestational Age
- Turner Syndrome
- Prader-Willi Syndrome
- Chronic Renal Insufficiency
- Short Bowel Syndrome
- Short Stature Homeobox Gene
Companies covered
- Novo Nordisk A/S (Denmark)
- Merck KgaA (Germany)
- Eli Lilly and Company (US)
- Pfizer, Inc. (US)
- Ferring Holding SA (Switzerland)
- Sandoz International GmbH (Germany)
- GeneScience Pharmaceuticals Co., Ltd. (China)
- Genentech, Inc. (US)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Growth Hormone Drugs Market Size (2021-2032)
- 2.2.2 Global Human Growth Hormone Drugs Sales (2021-2032)
- 2.2.3 Global Human Growth Hormone Drugs Market Average Price (2021-2032)
- 2.3 Human Growth Hormone Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Saizen
- 2.3.3 Genotropin
- 2.3.4 Humatrope
- 2.3.5 Norditropin
- 2.3.6 Omnitrope - the Somatropin Biosimilar
- 2.3.7 Somatropin Biopartners
- 2.4 Human Growth Hormone Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Small for Gestational Age
- 2.4.3 Turner Syndrome
- 2.4.4 Prader-Willi Syndrome
- 2.4.5 Chronic Renal Insufficiency
- 2.4.6 Short Bowel Syndrome
- 2.4.7 Short Stature Homeobox Gene
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Growth Hormone Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Growth Hormone Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Human Growth Hormone Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Growth Hormone Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Growth Hormone Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Growth Hormone Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Growth Hormone Drugs, Product Type & Application
- 3.8 Global Manufacturers of Human Growth Hormone Drugs, Established Date
- 3.9 Global Human Growth Hormone Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk A/S (Denmark)
- 4.1.1 Novo Nordisk A/S (Denmark) Company Information
- 4.1.2 Novo Nordisk A/S (Denmark) Business Overview
- 4.1.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio
- 4.1.5 Novo Nordisk A/S (Denmark) Recent Developments
- 4.2 Merck KgaA (Germany)
- 4.2.1 Merck KgaA (Germany) Company Information
- 4.2.2 Merck KgaA (Germany) Business Overview
- 4.2.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio
- 4.2.5 Merck KgaA (Germany) Recent Developments
- 4.3 Eli Lilly and Company (US)
- 4.3.1 Eli Lilly and Company (US) Company Information
- 4.3.2 Eli Lilly and Company (US) Business Overview
- 4.3.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio
- 4.3.5 Eli Lilly and Company (US) Recent Developments
- 4.4 Pfizer, Inc. (US)
- 4.4.1 Pfizer, Inc. (US) Company Information
- 4.4.2 Pfizer, Inc. (US) Business Overview
- 4.4.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio
- 4.4.5 Pfizer, Inc. (US) Recent Developments
- 4.5 Ferring Holding SA (Switzerland)
- 4.5.1 Ferring Holding SA (Switzerland) Company Information
- 4.5.2 Ferring Holding SA (Switzerland) Business Overview
- 4.5.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio
- 4.5.5 Ferring Holding SA (Switzerland) Recent Developments
- 4.6 Sandoz International GmbH (Germany)
- 4.6.1 Sandoz International GmbH (Germany) Company Information
- 4.6.2 Sandoz International GmbH (Germany) Business Overview
- 4.6.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio
- 4.6.5 Sandoz International GmbH (Germany) Recent Developments
- 4.7 GeneScience Pharmaceuticals Co., Ltd. (China)
- 4.7.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information
- 4.7.2 GeneScience Pharmaceuticals Co., Ltd. (China) Business Overview
- 4.7.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio
- 4.7.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments
- 4.8 Genentech, Inc. (US)
- 4.8.1 Genentech, Inc. (US) Company Information
- 4.8.2 Genentech, Inc. (US) Business Overview
- 4.8.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio
- 4.8.5 Genentech, Inc. (US) Recent Developments
5 Global Human Growth Hormone Drugs Market Scenario by Region
- 5.1 Global Human Growth Hormone Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Growth Hormone Drugs Sales by Region: 2021-2032
- 5.2.1 Global Human Growth Hormone Drugs Sales by Region: 2021-2026
- 5.2.2 Global Human Growth Hormone Drugs Sales by Region: 2027-2032
- 5.3 Global Human Growth Hormone Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Human Growth Hormone Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Human Growth Hormone Drugs Revenue by Region: 2027-2032
- 5.4 North America Human Growth Hormone Drugs Market Facts & Figures by Country
- 5.4.1 North America Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Growth Hormone Drugs Sales by Country (2021-2032)
- 5.4.3 North America Human Growth Hormone Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Human Growth Hormone Drugs Market Facts & Figures by Country
- 5.5.1 Europe Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Growth Hormone Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Human Growth Hormone Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Growth Hormone Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Growth Hormone Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Growth Hormone Drugs Market Facts & Figures by Country
- 5.7.1 South America Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Growth Hormone Drugs Sales by Country (2021-2032)
- 5.7.3 South America Human Growth Hormone Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Growth Hormone Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Human Growth Hormone Drugs Sales by Type (2021-2032)
- 6.1.1 Global Human Growth Hormone Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Human Growth Hormone Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Human Growth Hormone Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Human Growth Hormone Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Growth Hormone Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Human Growth Hormone Drugs Sales by Application (2021-2032)
- 7.1.1 Global Human Growth Hormone Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Human Growth Hormone Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Human Growth Hormone Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Human Growth Hormone Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Human Growth Hormone Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Growth Hormone Drugs Value Chain Analysis
- 8.1.1 Human Growth Hormone Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Growth Hormone Drugs Production Mode & Process
- 8.2 Human Growth Hormone Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Growth Hormone Drugs Distributors
- 8.2.3 Human Growth Hormone Drugs Customers
9 Global Human Growth Hormone Drugs Analyzing Market Dynamics
- 9.1 Human Growth Hormone Drugs Industry Trends
- 9.2 Human Growth Hormone Drugs Industry Drivers
- 9.3 Human Growth Hormone Drugs Industry Opportunities and Challenges
- 9.4 Human Growth Hormone Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst